Infliximab in children with inflammatory bowel disease in Italy: Efficacy

被引：0
|
作者：
Paganelli, M.
Ravelli, A.
Lionetti, P.
Martellossi, C.
DeAngelis, G.
Staiano, A.
Papadatu, B.
Accomando, S.
Barera, G.
Fontana, M.
Pannone, V.
Cucchiara, S.
机构：
来源：
DIGESTIVE AND LIVER DISEASE | 2007年 / 39卷 / 10期
关键词：
D O I：
10.1016/j.dld.2007.07.066
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A55 / A55
页数：1
相关论文
共 50 条
  • [1] Infliximab in children with inflammatory bowel disease in Italy: safety
    Paganelli, M.
    Lionetti, P.
    Lombardi, G.
    Ravelli, A.
    Barabino, A.
    Guariso, G.
    Catassi, C.
    Rutigliano, V.
    Cicala, M.
    Diaferia, P.
    Berni-Canani, R.
    Viola, F.
    Cucchiara, S.
    DIGESTIVE AND LIVER DISEASE, 2007, 39 (10) : A54 - A55
  • [2] Comparison of efficacy and safety of biosimilar infliximab to originator infliximab in children with inflammatory bowel disease
    Muhammed, R.
    Whyte, L.
    Protheroe, S.
    Bremner, R.
    Haller, W.
    Wong, T.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S291 - S291
  • [3] COMPARISON OF EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB TO ORIGINATOR INFLIXIMAB IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
    Muhammed, R.
    Wong, T.
    Haller, W.
    Protheroe, S.
    Whyte, L.
    Bremner, R.
    GUT, 2016, 65 : A259 - A260
  • [4] Impact of Body Mass Index on Efficacy of Infliximab in Children With Inflammatory Bowel Disease
    Grossi, Victoria
    Lerer, Trudy
    Markowitz, James
    Griffiths, Anne M.
    Evans, Jonathan
    Bousvaros, Athos
    Mack, David R.
    Otley, Anthony R.
    Pfefferkorn, Marian D.
    Rosh, Joel R.
    Oliva-Hemker, Maria
    Saeed, Shehzad A.
    Deslandres, Colette
    Carvalho, Ryan
    Grossman, Andrew B.
    Keljo, David J.
    Kappelman, Michael
    Hitch, Meredith C.
    Sudel, Boris
    Rick, James
    Cabrera, Jose
    Faubion, William A.
    Leleiko, Neal S.
    Hyams, Jeffrey S.
    GASTROENTEROLOGY, 2013, 144 (05) : S128 - S128
  • [5] Efficacy of infliximab for extraintestinal manifestations of inflammatory bowel disease
    Siemanowski B.
    Regueiro M.
    Current Treatment Options in Gastroenterology, 2007, 10 (3) : 178 - 184
  • [6] Infliximab Therapy in Children and Adolescents with Inflammatory Bowel Disease
    Gabor Veres
    Robert N. Baldassano
    Petar Mamula
    Drugs, 2007, 67 : 1703 - 1723
  • [7] Infliximab use in children and adolescents with inflammatory bowel disease
    de Ridder, Lissy
    Benninga, Marc A.
    Taminiau, Jan A. J. M.
    Hommes, Daan W.
    van Deventer, Sander J. H.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2007, 45 (01): : 3 - 14
  • [8] Infliximab therapy in children and adolescents with inflammatory bowel disease
    Veres, Gabor
    Baldassano, Robert N.
    Mamula, Petar
    DRUGS, 2007, 67 (12) : 1703 - 1723
  • [9] Efficacy and Safety of Infliximab in Older Inflammatory Bowel Disease Patients
    Lindenmeyer, Christina
    Moleski, Stephanie
    Whitsett, Maureen
    Kozuch, Patricia
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S509 - S509
  • [10] Efficacy and safety of infliximab and adalimumab in inflammatory bowel disease patients
    Kamal, Mahmoud E.
    Werida, Rehab H.
    Radwan, Mahasen A.
    Askar, Safaa R.
    Omran, Gamal A.
    El-Mohamdy, Marwa A.
    Hagag, Radwa S.
    INFLAMMOPHARMACOLOGY, 2024, 32 (05) : 3259 - 3269
12345